EVOFEM BIOSCIENCES, INC. — Revenue by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/38af4bdf-c686-42f0-ab53-5bf4f71409cf/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $20.2M | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-009686 |
| FY 2024 | $19.4M | 2024-01-01 – 2024-12-31 | evidence 0001641172-25-000188 |
| FY 2023 | $18.2M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-011404 |
| FY 2022 | $16.8M | 2022-01-01 – 2022-12-31 | evidence 0001493152-24-011404 |
| FY 2021 | $8.2M | 2021-01-01 – 2021-12-31 | evidence 0001618835-22-000057 |
| FY 2020 | $446.0k | 2020-01-01 – 2020-12-31 | evidence 0001618835-21-000040 |
| FY 2019 | $0 | 2019-01-01 – 2019-12-31 | evidence 0001618835-21-000040 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
EVOFEM BIOSCIENCES, INC. — all facts · Net Income · Operating Income